NASA Chases New Supernova

WASHINGTON—In the scramble to point every available instrument at the recently discovered supernova in the Large Magellanic Cloud, NASA plans a campaign of balloon flights, rocket launches and airborne observations to begin next month. The crash program, if approved by NASA Administrator James Fletcher, will cost $15 million. It will include 16 or 17 instrumented balloon flights extending through late next year, as well as sounding rocket flights and infrared observations using NASA's Kuip

Written byTony Reicilhardt
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The crash program, if approved by NASA Administrator James Fletcher, will cost $15 million. It will include 16 or 17 instrumented balloon flights extending through late next year, as well as sounding rocket flights and infrared observations using NASA's Kuiper Airborne Observatory (KAO). The space agency also plans to conduct Very Long Baseline Interferometry radio measurements to measure directly the size of the supernova's expanding shell.

Within a week of the discovery of SN1987A on February 24, NASA issued a "Dear Colleague" letter calling for gamma-ray and X-ray instruments that could be readied quickly for balloon or rocket flights. Three gamma-ray experiments already have been chosen for balloon flights in April and May, and a peer review of proposals for future flights will be conducted "within a few weeks," according to Alan Bunner of the agency's High Energy Astrophysics Branch. "We are looking for payloads that are ready or already ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies